Press releases | Corporate and M&A, Private Equity & Financial Sponsors, Tax |

KKR acquires life sciences company LGC

Overview

Travers Smith has advised the management team of LGC ("Management") on the sale of LGC to, and new shareholder arrangements with, KKR.

The Travers Smith team advising Management on the transaction was led by Senior Partner Chris Hale alongside Corporate Partner Adam Orr.  They were assisted by senior private equity associate Jeremy Dennison and private equity associates Adam Martin and Adrian Duncan. Tax partner Simon Skinner provided tax advice to Management.

LGC is an international life sciences company creating measurement and testing solutions for companies across the world. It has been owned by Bridgepoint since 2010. LGC operates globally in 22 countries and focuses on three distinct areas: the manufacture and distribution of reference materials, proprietary genomic products and the provision of analytical and genomics testing services. With over three quarters of its customers in the private sector and the balance in government and the public sector, LGC serves the pharma, AgBio, food and environmental sectors.

Other legal advisors working on the transaction include Shearman & Sterling (advising the institutional seller, Bridgepoint) and Simpson Thacher (advising KKR). 

The transaction is currently subject to normal regulatory approvals and is expected to complete in early 2016.